Adhera Therapeutics, Inc. (ATRX)
- Previous Close
0.0081 - Open
0.0080 - Bid --
- Ask --
- Day's Range
0.0060 - 0.0080 - 52 Week Range
0.0042 - 0.1499 - Volume
90,533 - Avg. Volume
70,531 - Market Cap (intraday)
43,325 - Beta (5Y Monthly) -0.02
- PE Ratio (TTM)
-- - EPS (TTM)
-1.1700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
adherathera.comRecent News: ATRX
Performance Overview: ATRX
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATRX
Valuation Measures
Market Cap
43.33k
Enterprise Value
10.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
11.45
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-532.88%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.61M
Diluted EPS (ttm)
-1.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
32.39k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
563.75k
Research Analysis: ATRX
Company Insights: ATRX
ATRX does not have Company Insights